Sec Form 4 Filing - YACHMETZ PHILIP K @ PROGENICS PHARMACEUTICALS INC - 2004-05-05

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
YACHMETZ PHILIP K
 2. Issuer Name and Ticker or Trading Symbol
PROGENICS PHARMACEUTICALS INC [ PGNX] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
VP, General Counsel
(Last) (First) (Middle)
YACHMETZ, PHILIP K., 4 VALLEY FORGE ROAD 		3. Date of Earliest Transaction (MM/DD/YY)
05/05/2004
(Street)
OAKLAND, NJ07436 		4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4) 		7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $0.0013 per share ("Common Stock") 05/03/2004 M 2,000 A $ 12.29 0 ( 1 ) D
Common Stock 05/03/2004 S 539 D $ 19.15 0 ( 1 ) D
Common Stock 05/03/2004 S 100 D $ 19.2 0 ( 1 ) D
Common Stock 05/03/2004 S 100 D $ 19.28 0 ( 1 ) D
Common Stock 05/03/2004 S 500 D $ 19.29 0 ( 1 ) D
Common Stock 05/03/2004 S 761 D $ 19.3 7,696 ( 1 ) D
Common Stock 200 I By Trust for Benefit of Daughter
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5) 		6. Date Exercisable and Expiration Date
(MM/DD/YY) 		7. Title and Amount of Underlying Securities
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4) 		10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4) 		11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Common Stock $ 12.29 05/05/2004 M 2,000 ( 1 ) ( 1 ) 06/30/2012 Common Stock 2,000 $ 1 33,000 ( 1 ) D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
YACHMETZ PHILIP K
YACHMETZ, PHILIP K.
4 VALLEY FORGE ROAD
OAKLAND, NJ07436		 VP, General Counsel
Signatures
Philip K. Yachmetz 05/05/2004
Signature of Reporting Person Date
Explanation of Responses:
( 1 )On July 1, 2002, the Reporting Person received from the Issuer, pursuant to the Issuer's 1996 Stock Option Plan, options to acquire 35,000 shares of Common Stock of the Issuer. The Stock Option became exercisable in equalinstallments over 4 years on each June 30th, with the last portion becoming exercisable on June 30, 2006. The Reporting Person previously exercised zero (0) options under this Grant. The Reporting Person is exercising the vestedportion of this Grant (8,750 options) in pre-established increments under and in accordance with the provisions of a previously established Plan of Sale under Rule 10b5-1, which was established in accordance with thepolicies and procedures of the Issuer approved by its Board of Directors.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.